Literature DB >> 22155731

Synovial fluid CD34⁻ CD44⁺ CD90⁺ mesenchymal stem cell levels are associated with the severity of primary knee osteoarthritis.

D-H Lee1, C H Sonn, S-B Han, Y Oh, K-M Lee, S-H Lee.   

Abstract

To the best of our knowledge, no reports have directly compared synovial fluid (SF)- and synovial membrane (SM)-derived mesenchymal stem cells (MSCs) from primary knee osteoarthritis patients in terms of MSC proportion, either immediately after isolation or during culture. Any possible correlation between SM- and SF-MSC purity and osteoarthritis severity, also remains unclear. We therefore assessed quantitative and phenotypic differences in MSCs isolated from SF and SM. We also evaluated the correlation between sample MSC purity, and disease severity, in patients with osteoarthritis. The main result of the current study was that the mean SF-MSC proportion at passage 0 was negatively correlated with Kellgren-Lawrence (KL) grade (r = -0.565, P = 0.002). In addition, KL grade was a only significant independent negative predictor of SF-MSC proportion at passage 0 (β = -0.356, P = 0.039). Conclusively, the proportion of SF-MSCs in fresh samples, evaluated at the single cell level, was inversely correlated with osteoarthritis severity.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155731     DOI: 10.1016/j.joca.2011.11.010

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  18 in total

Review 1.  Mesenchymal stem cells in joint disease and repair.

Authors:  Frank Barry; Mary Murphy
Journal:  Nat Rev Rheumatol       Date:  2013-07-23       Impact factor: 20.543

2.  Differential cytotoxicity of corticosteroids on human mesenchymal stem cells.

Authors:  Cody C Wyles; Matthew T Houdek; Saranya P Wyles; Eric R Wagner; Atta Behfar; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2014-09-04       Impact factor: 4.176

3.  Protein-releasing polymeric scaffolds induce fibrochondrocytic differentiation of endogenous cells for knee meniscus regeneration in sheep.

Authors:  Chang H Lee; Scott A Rodeo; Lisa Ann Fortier; Chuanyong Lu; Cevat Erisken; Jeremy J Mao
Journal:  Sci Transl Med       Date:  2014-12-10       Impact factor: 17.956

Review 4.  Microfluidic sample preparation for diagnostic cytopathology.

Authors:  Albert J Mach; Oladunni B Adeyiga; Dino Di Carlo
Journal:  Lab Chip       Date:  2013-03-21       Impact factor: 6.799

Review 5.  Stem cell-based therapies for osteoarthritis: challenges and opportunities.

Authors:  Brian O Diekman; Farshid Guilak
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

6.  Mesenchymal stem cells in synovial fluid increase after meniscus injury.

Authors:  Yu Matsukura; Takeshi Muneta; Kunikazu Tsuji; Hideyuki Koga; Ichiro Sekiya
Journal:  Clin Orthop Relat Res       Date:  2013-12-13       Impact factor: 4.176

Review 7.  Synovial fluid and synovial membrane mesenchymal stem cells: latest discoveries and therapeutic perspectives.

Authors:  Eduardo Branco de Sousa; Priscila Ladeira Casado; Vivaldo Moura Neto; Maria Eugenia Leite Duarte; Diego Pinheiro Aguiar
Journal:  Stem Cell Res Ther       Date:  2014-10-03       Impact factor: 6.832

8.  Abrasion arthroplasty increases mesenchymal stem cell content of postoperative joint effusions.

Authors:  Rainer Beckmann; Sebastian Lippross; Claudia Hartz; Mersedeh Tohidnezhad; Mónica S Ventura Ferreira; Sabine Neuss-Stein; Andreas Seekamp; Sven Nebelung; Nisreen Kweider; Björn Rath; Holger Jahr; Thomas Pufe; Deike J Varoga
Journal:  BMC Musculoskelet Disord       Date:  2015-09-12       Impact factor: 2.362

9.  Synovium fragment-derived cells exhibit characteristics similar to those of dissociated multipotent cells in synovial fluid of the temporomandibular joint.

Authors:  Yang-peng Sun; You-hua Zheng; Wen-jing Liu; Yu-liang Zheng; Zhi-guang Zhang
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

10.  Upregulation of miR-23b enhances the autologous therapeutic potential for degenerative arthritis by targeting PRKACB in synovial fluid-derived mesenchymal stem cells from patients.

Authors:  Onju Ham; Chang Youn Lee; Byeong-Wook Song; Se-Yeon Lee; Ran Kim; Jun-Hee Park; Jiyun Lee; Hyang-Hee Seo; Chae Yoon Lee; Yong-An Chung; Lee-So Maeng; Min Young Lee; Jongmin Kim; Jihwan Hwang; Dong Kyun Woo; Woochul Chang
Journal:  Mol Cells       Date:  2014-06-11       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.